$RNN Recent News Rexahn prices offering at 30%

$RNN Recent News

Rexahn prices offering at 30% discount 11:58 a.m. Nov. 29, 2012 - MarketWatch.com
AEterna falls; Inspire, Rexahn rally 3:15 p.m. April 16, 2010 - Val Brickates Kennedy
Javelin rockets, Myriad gains on scrapped merger 1:20 p.m. April 12, 2010 - Val Brickates Kennedy
Wednesday's biggest gaining and declining stocks 4:26 p.m. April 7, 2010 - MarketWatch
Rexahn, Avanir gain; Sequenom falls 1:32 p.m. April 7, 2010 - Val Brickates Kennedy
Letter up 230% last year without trading 4:00 a.m. Jan. 11, 2010 - Peter Brimelow

Rexahn +7.9% AH after RX-3117 receives orphan status 5:55 p.m. Sept. 24, 2014 - Seeking Alpha
Rexahn Pharmaceuticals (RNN) Jumps: Stock Rises 9.6% - Tale of the Tape 9:39 a.m. Sept. 4, 2014 - Zacks.com
Rexahn receives NOA for drug delivery platform patent 1:40 p.m. Sept. 3, 2014 - Seeking Alpha
Update: Rexahn Q2 Earnings - Stock Down, But My Optimism Remains Intact 1:14 a.m. Aug. 15, 2014 - Seeking Alpha
10-Q: REXAHN PHARMACEUTICALS, INC. 7:39 a.m. Aug. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Rexahn provides update on Supinoxin trial 9:30 a.m. July 18, 2014 - Seeking Alpha
What Falling Estimates & Price Mean for Rexahn Pharmaceuticals (RNN) - Tale of the Tape 8:45 a.m. June 16, 2014 - Zacks.com
Rexahn Pharmaceuticals (RNN) Jumps: Stock Surges 19.2% - Tale of the Tape 9:46 a.m. May 16, 2014 - Zacks.com
More on Rexahn Q1 results and pipeline update 11:42 a.m. May 15, 2014 - Seeking Alpha
10-Q: REXAHN PHARMACEUTICALS, INC. 5:10 p.m. May 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Rexahn Pharmaceuticals: An Undervalued Oncology Play With Risk Diversification 5:07 p.m. May 14, 2014 - Seeking Alpha
Success Of Rexahn's Nano-Sized Taxotere Can Help Big Pharma Ease Patent Cliff 4:23 p.m. April 21, 2014 - Seeking Alpha
10-K: REXAHN PHARMACEUTICALS, INC. 4:21 p.m. March 21, 2014 - Edgar Online - (EDG = 10Q, 10K)
Phase I Data on Rexahn's Supinoxin - Analyst Blog 5:30 p.m. March 12, 2014 - Zacks.com
Rexahn Pharma up 10% 1:26 p.m. March 11, 2014 - Seeking Alpha
Rexahn cancer drug safe so far in Phase I study, shares jump 8:33 a.m. March 11, 2014 - Seeking Alpha
Rexahn Pharmaceuticals: Another $1.30 Biotech Lottery Ticket 1:14 p.m. Feb. 27, 2014 - Seeking Alpha
Following Unmet Needs To Biotech Profits: Echo He 3:16 p.m. Jan. 31, 2014 - Seeking Alpha
Rexahn Pharmaceuticals (RNN) Jumps: Stock Up 5.3% - Tale of the Tape 10:39 a.m. Jan. 27, 2014 - Zacks.com
Rexahn Pharmaceutical Shares Are Still A Buy Despite Recent Volatility 4:38 p.m. Jan. 15, 2014 - Seeking Alpha


Market Movers - Biotech Stocks - Hemispherx Biopharma, Aegerion Pharma, Cytori Therapeutics, Alnylam Pharma, and Rexahn Pharma 55 min ago - PR Newswire - PRF
Rexahn Receives FDA Orphan Drug Designation for RX-3117 in Treatment of Pancreatic Cancer 4:31 p.m. Sept. 24, 2014 - GlobeNewswire
Rexahn Pharmaceuticals to Present at the 14th Annual Biotech in Europe Investor Forum for Global Partnering and Investment in Basel, Switzerland 9:01 a.m. Sept. 23, 2014 - GlobeNewswire
Rexahn Pharmaceuticals to Present at the BioPharm America™ 2014 in Boston, Massachusetts, USA 9:02 a.m. Sept. 16, 2014 - BusinessWire - BZX
Rexahn Pharmaceuticals to Present at the 16th Annual Rodman & Renshaw Global Investment Conference on September 9,2014 9:00 a.m. Sept. 4, 2014 - BusinessWire - BZX
Rexahn Receives a Notice of Allowance from the U.S. Patent and Trademark Office for a Novel Targeted Cancer Drug Delivery Platform 9:01 a.m. Sept. 3, 2014 - BusinessWire - BZX
Market Movers - Biotech Stocks -- Progenics Pharma, Rexahn Pharma, ImmunoGen, Hemispherx Biopharma, and Incyte 9:20 a.m. Aug. 21, 2014 - PR Newswire - PRF
Epigenetic R&D, Therapies and Diagnostics: Industry and Market Prospects 2014-2024 1:22 p.m. Aug. 19, 2014 - PR Newswire - PRF
Rexahn Pharmaceuticals Reports Second Quarter 2014 Financial Results and Pipeline Update 9:01 a.m. Aug. 14, 2014 - BusinessWire - BZX
Rexahn Pharmaceuticals Provides Update on Phase I Supinoxin Trial in Cancer Patients with Solid Tumors 9:01 a.m. July 18, 2014 - BusinessWire - BZX
Stocks Coverage on Biotech Equities -- Research on Gilead Sciences, ARIAD Pharma, Rexahn Pharma, and Geron 7:10 a.m. May 30, 2014 - PR Newswire - PRF
Three biotechs stocks with positive institutional transactions, good price to cash ratios and "buy" recommendations from street analysts 8:09 a.m. May 22, 2014 - ACCESSWIRE
Pharmaceutical Development & Medical Cannabis Expand at an Aggressive Rate - Company Attracts Major Attention at WebCongress Conference in San Francisco 9:20 a.m. May 16, 2014 - PR Newswire - PRF
Rexahn Pharmaceuticals Reports First Quarter 2014 Financial Results and Pipeline Update 9:03 a.m. May 15, 2014 - BusinessWire - BZX
Rexahn Announces Additional Data from Preclinical Studies of RX-3117 9:02 a.m. May 8, 2014 - BusinessWire - BZX
Biotech Stocks Review -- Research on Retrophin, Merrimack, Gilead Sciences, and Rexahn Pharma 12:37 p.m. May 6, 2014 - PR Newswire - PRF
Active Equities Updates -- Research on Valero Energy, UTi Worldwide, SLM Corp., and Rexahn Pharma 9:00 a.m. April 1, 2014 - PR Newswire - PRF
Rexahn Pharmaceuticals to Present at the 2nd Annual Sachs Cancer Bio Partnering & Investment Forum in New York 8:01 a.m. March 17, 2014 - BusinessWire - BZX
Investor-Edge.com Pre-market Biotech Picks: Rexahn Pharma, Amgen, Galena Biopharma, and MannKind 11:32 a.m. March 11, 2014 - PR Newswire - PRF
Rexahn Announces Initial Results from Phase I Trial of SupinoxinTM (RX-5902) for Solid Cancer Tumors 8:01 a.m. March 11, 2014 - BusinessWire - BZX